Lyme disease defense US BIOLOGIC is actively launching LymeShield System to prevent tick-borne diseases at the source, creating a compelling entry point for partnerships with pest management, wildlife health, and veterinary networks seeking proactive prevention solutions.

Wildlife and human health The company targets prevention across wildlife, companion animals, food animals, and humans, suggesting cross-sector opportunities with ecosystem health programs, veterinary clinics, livestock producers, and public health initiatives.

Oral vaccine platform An oral-delivery platform that leverages proven technologies offers a scalable route for funding, regulatory support, manufacturing, and distribution—opening conversations with contract manufacturers, distributors, and grant-funded programs.

Strategic partnerships Recent collaborations with pest management firms and public health partners indicate a receptiveness to channel partnerships and co-development deals to expand market reach and accelerate adoption of the LymeShield and related vaccines.

Moderate revenue growth With reported revenue between one and ten million and a lean team, there is potential to upsell manufacturing, regulatory services, and distribution capabilities to larger animal health players seeking to diversify portfolios and scale vaccines.